Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09RNP
|
|||
| Former ID |
DCL000667
|
|||
| Drug Name |
GSK 679769
|
|||
| Indication | Anxiety disorder [ICD-11: 6B00-6B0Z] | Discontinued in Phase 2 | [1] | |
| Chemotherapy-induced nausea [ICD-11: MD90; ICD-10: R11] | Discontinued in Phase 2 | [1] | ||
| Incontinence [ICD-11: MF50.2] | Discontinued in Phase 2 | [1] | ||
| Major depressive disorder [ICD-11: 6A70.3; ICD-10: F32.2] | Discontinued in Phase 2 | [1] | ||
| Company |
GlaxoSmithKline
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Substance-P receptor (TACR1) | Target Info | Antagonist | [1] |
| KEGG Pathway | Calcium signaling pathway | |||
| Neuroactive ligand-receptor interaction | ||||
| Measles | ||||
| Panther Pathway | CCKR signaling map ST | |||
| Reactome | G alpha (q) signalling events | |||
| WikiPathways | SIDS Susceptibility Pathways | |||
| Gastrin-CREB signalling pathway via PKC and MAPK | ||||
| Spinal Cord Injury | ||||
| Peptide GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Emerging drugs for chemotherapy-induced emesis. Expert Opin Emerg Drugs. 2006 Mar;11(1):137-51. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.